This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Educational Activity

Facilitating Treatment Initiation in Early-Stage Alzheimer Disease

Anna D. Burke, MD, and Danielle Goldfarb, MD

Published: August 1, 2022

Once a diagnosis of Alzheimer disease is established, a wide variety of therapy options are available to treat different stages of the disease. Patients have the opportunity to delay onset of the disease or delay its progression if diagnosed early enough through new FDA-approved disease-modifying treatments. For mild to moderate stages, new symptomatic treatments can slow the progression of the disease and improve symptoms.  A multi-component approach is recommended in order to tailor treatments to each patient’s needs.

See the entire activity

To cite: Burke AD, Goldfarb D. Facilitating treatment initiation in early-stage Alzheimer disease. J Clin Psychiatry. 2022;83(4):LI21019DH2C
To share:

© Copyright 2022 Physicians Postgraduate Press, Inc.


Volume: 83

Quick Links: